Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine label

被引：12
作者：
Dal-Re, Rafael [1 ]
Launay, Odile [2 ,3 ]
机构：
[1] Univ Autonoma Madrid, Fdn Jimenez Diaz, Univ Hosp, Epidemiol Unit,Hlth Res Inst, Avda Reyes Catolicos 2, E-28040 Madrid, Spain
[2] Univ Paris, Innovat Clin Res Network Vaccinol I REIVAC, Fac Med, INSERM,CIC 1417,F CRIN, Paris, France
[3] Hop Cochin Paris, AP HP, CIC Cochin Pasteur, Paris, France
来源：
VACCINE | 2021年 / 39卷 / 30期
关键词：
D O I：
10.1016/j.vaccine.2021.05.095
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：4029 / 4031
页数：3
相关论文
共 17 条
  • [1] Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021
    Abu Jabal, Kamal
    Ben-Amram, Hila
    Beiruti, Karine
    Batheesh, Yunis
    Sussan, Christian
    Zarka, Salman
    Edelstein, Michael
    [J]. EUROSURVEILLANCE, 2021, 26 (06)
  • [2] [Anonymous], 2021, REUTERS 0205
  • [3] [Anonymous], 2021, Euronews
  • [4] [Anonymous], 2021, BBC News
  • [5] Will AstraZeneca be able to provide clinical trial data on its COVID-19 vaccine efficacy in older adults?
    Dal-Re, Rafael
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (05) : 2405 - 2406
  • [6] Trial participants' rights after authorisation of COVID-19 vaccines
    Dal-Re, Rafael
    Orenstein, Walter
    Caplan, Arthur L.
    [J]. LANCET RESPIRATORY MEDICINE, 2021, 9 (04) : E30 - E31
  • [7] European Commission, QUEST ANSW COND MARK
  • [8] European Medicines Agency, CLAR COMM DOS INT 20
  • [9] European Medicines Agency, COVID 19 VACCINE AST
  • [10] European Parliament, 2020, PARL QUEST 4 DEC 202
12